LFB1/HNF1 is a hepatocyte-enriched frans-activator involved in the regulation of many liver-specific genes. We report the cloning and characterization of a rat genomic DNA fragment containing about 3.5 kb of the LFB1/HNF1 gene 5'-flanking region. This DNA segment is capable of directing the liver-specific expression of a reporter gene in transfection assays. More interestingly, the basal activity of the LFB1/HNF1 promoter in cultured hepatoma cell lines is downregulated by exogenously added LFB1/HNF1 protein itself. The ability to repress transcription starting from its own promoter requires the integrity of the N-terminal LFB1/HNF1 DNA-binding domain. Contrary to the expectations, in vitro binding experiments failed to demonstrate any specific and functional interaction of purified LFB1/HNF1 with the -3 . 5 kb promoter sequence. In addition to the DNA-binding domain, a 60 aa region contained in the C-terminus of the protein and distinct from the previously characterized activation domains, is also required for the repressing function.
INTRODUCTION
The liver provides a useful model system in which to study the mechanisms that govern the differential expression of tissuespecific genes (1) . Several cDNAs coding for factors that play an important role in controlling the hepatocyte-specific expression have recently been cloned. They include the Liver Factor Bl/Hepatocyte Nuclear Factor 1 (LFB1/HNF1; 2,3) and the related factor LFB3/vHNFl (4, 5) , the Drosophila fork head homologue HNF3 (6), HNF4, a member of the steroid hormone receptor superfamily (7) and the leucine-zipper containing factors C/EBP (8) and DBP (9) . The interaction of these transcription factors with a given array of ds-acting elements on the promoter region of liver-specific genes modulates their expression rate. This interaction may in fact activate or repress promoter activity according to the stage of development, hormonal induction or pathological condition (10) . The comprehension of the molecular mechanisms underlying hepatocyte-specific transcriptional regulation may provide insight into the events leading to liver development and differentiation.
LFB1/HNF1 was initially identified as a hepatocyte factor interacting with the promoter regions of many liver-specific genes (10, 11) . Although its expression was shown not to be limited to hepatic cells, both in vivo and in vitro studies have confirmed this protein to be one of the major determinants of the liver phenotype (5, (12) (13) (14) .
LFB1/HNF1 binds as a dimer to specific palindromic sites (2, 11, 15) . The functional architecture of the LFB1/HNF1 protein has been extensively studied in our laboratory. A protein fragment that contains the N-terminal 281 residues of LFB1/HNF1 binds to DNA with affinity and specificity comparable to those of the native protein (2) . Further dissection of this minimal DNAbinding domain revealed a unique tripartite DNA binding structure that includes an unusually long homeodomain, a region related to the POU-specific A-box, and a short N-terminal dimerization domain (15, 16) . The C-terminus of the molecule (aa 282-628) contains at least three regions that have been shown to be indispensable for the transcription activation function: the serine-rich ADI (Activation Domain I, aa 547-628), the prolinerich ADII (aa 282-318) and the glutamine-rich ADm (aa 440-506) (15, 17, 18) .
The cloning and functional characterization of the rat and mouse LFB1/HNF1 promoter region was reported (19, 20) . It has been shown that the activity of this promoter in cultured hepatoma cell lines can be enhanced by co-transfection with cDNAs coding for the hepatocyte-enriched fra/u-activators HNF4 and HNF3 (19, 20) .
Autoregulation is a common mechanism through which the correct balance between transcription factors is established and mantained during the developmental stages of the cells or in response to external stimuli (21) (22) (23) . Conflicting results have been reported about the role of LFB1/HNF1 in regulating the transcriptional activity of the promoter of its gene (24) (25) (26) . In this paper we show evidences of a negative autoregulatory loop, through which LFB1/HNF1 negatively controls transcription driven from a 3500 bp fragment of its own promoter. We show that an intact DNA-binding domain and a region contained in the C-terminal moiety of the protein are both required for the autorepressing activity of LFB1/HNF1, even though direct binding to the promoter sequence could not be demonstrated.
MATERIALS AND METHODS
Isolation of the LFB1/HNF1 promoter region 2.5 X10 6 recombinant phage plaques from an amplified EMBL-3 rat genomic library were screened by hybridization with a labelled DNA fragment encompassing positions 1/1840 of the LFB1/HNF1 cDNA (XI8; 2). Plating of the phages and duplicate lifts were done by standard procedures (27) . Lifts were presoaked in 6xSSC (0.9 M NaCl, 0.09 M Na Citrate), lxDenhardt's, 100 /tg/ml salmon sperm DNA and hybridized in the same buffer containing the labelled probe for 16 h at 65°C. Filters were washed three times in 6 XSSC, 0.1 % SDS and once in 0.2 x SSC, 0.1% SDS for 3O'at 65°C. The DNA was purified from one positive clone (X4-5) (28) after tertiary screening and characterized by restriction digestion revealing a 30 kb long insert. Southern blot analysis identified a 3.7 kb Sacl-Sacl fragment, hybridizing with the X18 probe. This fragment was subcloned in the Sad site of the pUC19 vector (construct S2/12) and sequenced.
DNA sequencing
To obtain the complete sequence of the LFB1/HNF1 5'-flanking region, several overlapping fragments from the 3.7 kb insert of the S2/12 construct (Sacl-EcoRl, positions 1/1271; Psil-Pstl, positions 220/2205 and 2205/3760; Hindi-EcoRL, positions 457/1271; Alul-Alul, positions 691/750 and 1316/1885; Smal-Sacl, positions 3138/3772; Sau3M-Sau3Al, positions 2561/3005) were subcloned into pUC19. Each insert was sequenced on both strands by the dideoxy method (29) , using forward and reverse M13 primers flanking the cloning sites, or internal synthetic primers.
Plasmid constructions
The plasmid pE8U-3.5CAT, used in the transfection experiments, was obtained by sub-cloning the 3598bp Sacl/Spel fragment (positions -3510/ + 88, relatively to the transcription starts site) from the S2/12 plasmid, in the Smal site of the pE8UCAT polylinker (30) , upstream of the chloramphenicol acetyltransferase (CAT) gene, after filling-in with Klenow polymerase. The strong transcription terminator from the mos gene, contained in the pE8UCAT vector, minimizes artifactual readthrough transcription from cryptic vector promoters.
The RSV-LFB1 construct, expressing the full-lenght LFB1/HNF1 protein under the control of the Rous Sarcoma Virus LTR promoter (RSV) in the pGM-4 vector has been already described (31) . To construct the plasmid H2-HNF4, the Bamiil-BamHl fragment from pLEN4S (kindly provided by J.E.Darnell), containing the full-lenght HNF4 protein, was filledin with Klenow and cloned into the Nhel-Xhol sites, both blunted, of the pH2 expression vector (5) . For the construction of the hybrid protein TAT/LFB1, a DNA fragment coding for the aminoacid region from A 2 i to F 3g of the HIV TAT protein has been obtained by filling-in of two partially complementary single stranded oligos. This fragment has been cloned into the Ncol-Sphl sites, both blunt-ended with Klenow enzyme, of the LFB1/HNF1 mutant Al in the BlueScript vector (15; bsTAT/LFBl). The Al vector was previously mutagenized to destroy a second Ncol site present in the LFB1/HNF1 coding sequence. Th Nhel-BglU fragment from bsTAT/LFBl, containing the TAT/LFB1 chimaera in the context of full-length LFB1/HNF1 protein, was subsequently cloned into the Xbal-Bamm sites of pGM-4 (RVS-TAT/LFB1).
The construction of RSV-GAL4/LFB1 and the LFB1/HNF1 C-terminal deletions, including the RSV-LFB1AC281 which expresses the LFB1/HNF1 DNA binding domain, has been already described in detail (18) .
Cell cultures, DNA transfections and CAT assays HepG2 and HeLa cell lines were cultured in Dulbecco's modified Eagle's medium + 10% fetal calf serum (FCS) at 5% CO 2 . H4 H and H5 were cultured in a 1:1 mixture of F12/NCTC-135 media (GIBCO/FLOW) + 10% FCS at 7% CO 2 .
DNA transfections were performed with the calcium phosphate precipitation technique as previously reported (32) . Each cell line was transfected with an aliquot of a precipitate prepared in duplicate. In each experiment 200 ng of CMV-luciferase plasmid were transfected as an internal control for transfection efficiency. Cells were harvested 36 h after transfection; CAT activity was assayed in whole-cell extracts according to Gorman et al. (33) and normalized to the luciferase activity present in the same extract, measured as described (34) .
Western immunoblot
Nuclear extracts from HepG2 cells, not transfected or transfected, were prepared as described (18) and separated on a 10% PA-GE/SDS gel. The gel was then electroblotted on nitrocellulose membrane and subsequently immunostained using a 1:1 mixture of a polyclonal antibody generated against the last 30 aminoacids at COOH-terminal and a polyclonal antibody generated against the DNA binding domain of the LFB1/HNF1 protein.
RESULTS

LFB1/HNF1 acts as a negative regulator of its own promoter
In order to isolate the LFB1/HNF1 promoter sequence, a DNA segment spanning the 5' region of the rat LFB1/HNF1 cDNA (XI8; 2) was used as a probe to screen a rat genomic EMBL-3 library. A positive clone (X4-5) containing a 3.7 kb Sacl-Sacl insert was isolated and sequenced. The isolated DNA sequence (not shown) contained 185 nucleotides of the LFB1/HNF1 cDNA coding sequence up to the previously characterized Sad site (2) and about 3.5 kb of the 5'-untranslated region.
To test the competence of this DNA segment to direct tissuespecific transcription the 5' flanking region of the LFB1/HNF1 gene from nucleotide -3515 to +88 (relatively to the transcription start site) was linked to the bacterial chloramphenicol acetyltransferase (CAT) reporter gene in the pE8UCAT eukaryotic expression vector (30) . The activity of the resulting construct, called pE8U-3.5CAT, was tested in transfection experiments using cell lines of hepatic (HepG2) and non hepatic origin (HeLa). The results indicate that the -3.5kb LFB1/HNF1 promoter segment is capable of directing efficient transcription in human hepatoma cells (HepG2, Fig.lA) , in which the endogenous LFB1/HNF1 gene is expressed, but not in cells, which do not contain any detectable LFB1/HNF1 activity (HeLa cells; data not shown). This finding suggests that the -3 . 5 kb 5'-flanking region of the LFBl/HNFl gene contains ris-acting elements sufficient for its cell-type specific expression at least ex vivo. In order to test the possibility that an autoregulatory loop might be involved in the control of the LFBl/HNFl gene expression, pE8U-3.5CAT was used as reporter plasmid and transfected together with increasing amounts of an LFBl/HNFl expression construct (RSV-LFBl, 31) in both HeLa and HepG2 cells. No CAT activity was detectable when HeLa were used as recipient cells, even at the highest concentration of the cotransfected LFBl/HNFl expression plasmid (data not shown). This result indicates that LFBl/HNFl is not capable of acting as a positive regulator of its own transcription. On the contrary, increasing amounts of RSV-LFBl incrementally decreased the -3 . 5 kb promoter activity in HepG2 cells (Fig.lA) . At the highest concentration used, more than 80% reduction of the promoter activity was observed. In a series of cotransfection experiments performed in parallel we confirmed that RSV-LFBl directs the synthesis of a stable protein, capable of transactivating an LFBl/HNFl-responsive promoter (CRP-CAT; 5) both in HepG2 (Fig. IB) and HeLa cells (5, 18) . It has to be pointed out that no repression could be observed under the same experimental conditions on different promoters, such as RSV (Fig.lC) and CMV (not shown), which do not contain LFBl/HNFl DNAbinding sites.
It has been shown that the liver-specific transcription factor HNF4 is a major determinant of the cell-specific expression of the LFBl/HNFl gene (19, 20) . Consistent with these reports, we have found that HNF4 is also able to transactivate the -3.5kb LFBl/HNFl promoter fragment: a strong CAT gene expression from this promoter fragment has been obtained in HeLa cells in cotransfection experiments with increasing amounts of the HNF4 protein expressed under the control of the H2 promoter (H2-HNF4; Fig.2) . The possibility to obtain the expression of the LFBl/HNFl promoter in non-hepatic cells upon the cotransfection of the HNF4 protein, has been used to verify whether the autorepression activity of LFBl/HNFl was restricted to cells of hepatic origin. We therefore performed experiments in HeLa cells in which the expression of the -3.5kb LFB1 promoter was allowed by the cotransfection of H2-HNF4 and then challenged with increasing amounts of RSV-LFBl. The results, reported in Fig. 2 , show that LFBl/HNFl is able to transinhibit its own promoter expression even in cells where the gene is not normally expressed, suggesting that the observed autorepression is not a tissue-specific phenomenon. 
The LFB1/HNF1 dimerization domain is not directly involved in the LFB1/HNF1 promoter autoregulation
As a first step toward the elucidation of the molecular mechanisms underlaying the LFB1/HNF1 promoter autoregulation, we decided to determine which portions of the protein are necessary to confer transcription repressing properties. The dimerization domain of LFB1/HNF1 has been mapped to the N-terminal 32 amino acid residues of the protein (15) . This region is crucial for the activity of the protein. In fact, LFB1/HNF1 binds efficiently and specifically to DNA only as a dimeric molecule. It has also been shown that the dimerization domain of the protein is responsible for the formation of heterodimers with the transcription factor LFB3/vHNFl (5, 35) . The same region has been shown to be involved in the interaction with another protein, DCoH, which is present in several tissues and cell lines (36) . It is therefore conceivable that, through its dimerization domain, the exogenously-added LFB1/HNF1 could sequester a related transcription factor or a cofactor that is essential for the LFB1/HNF1 promoter activity thus repressing its expression.
In previous studies we have shown that the dimerization domain of LFB1/HNF1 behaves as an independent module and can be substituted with dimerization domains derived from other proteins (15, 16) . The resulting chimeric molecules still bind in vitro to the LFB1/HNF1 recognition sequence (37) . To establish whether the negative effect of LFB1/HNF1 on the expression of its own promoter is mediated by its dimerization domain, a substitution mutant was constructed, in which the 32 N-terminal residues of LFB1/HNF1 were changed with a 16 aminoacid sequence responsible for the dimerization of the HTV TAT protein (38, 40) . The resulting hybrid protein (TAT/LFB1) binds as a homodimer to the LFB1/HNF1 recognition sequence and stimulates LFB 1/HNF1-dependent promoters, but is neither able to heterodimerize with the LFB1/HNF1 wild-type molecule, nor to interact with the DCoH protein (L.T. and R.D.F., unpublished results). If the autorepression of LFB1/HNF1 of its own promoter activity depended on its participation in a heteromeric complex involving protein-protein interactions through the dimerization domain, we expected that the TAT/LFB1 chimaera would not be able to mediate autorepression. On the contrary, we found that the TAT/LFB1 hybrid protein, expressed under the control of the RSV promoter, retains the ability to repress transcription from the -3 . 5 kb LFB1/HNF1 promoter (Fig. 3A) , while is able to activate an LFB1/HNF1 dependent promoter (CRP-CAT; Fig.  3B ). The promoter repression by TAT-LFB1 is slightly less potent than that by the wild type protein. This could depend on lower DNA binding affinity or on a decreased stablility of the TAT-LFB1 dimer in vivo, even though we have observed no significant impairment of DNA binding or dimerization properties in vitro.
On the basis of these results, we can reasonably exclude that LFB1/HNF1 mediates repression of its own promoter by sequestering a critical protein factor through its dimerization domain. In addition, this experiment proves that the repression can be attributed to the homodimeric form of LFB1/HNF1.
Regions within both the DNA-binding domain and the Cterminal half of the LFB1/HNF1 protein are required for repression
In previous studies it was shown that the N-terminal 281 aminoacids of LFB1/HNF1 are necessary and sufficient for sequence-specific DNA binding but lack the ability to transactivate LFB 1/HNF1-dependent promoters (2, 15) .
The negative effect of LFB1/HNF1 on the activity of its own promoter could be due to a competition for binding to a common or overlapping site between LFB1/HNF1 and an unknown, but more potent, activating factor. In this case, one would expect that the isolated DNA-binding domain should still be able to repress transcription from the LFB1/HNF1 promoter. As shown in Fig. 4A , increasing amounts of transfected LFB1/HNF1 DNAbinding domain have no effect on transcription of the CAT gene starting from the -3.5kb LFB1/HNF1 promoter, even though a stable protein is expressed in transfected cells as assayed by Western blot (Fig.4B) .
These observations raised the possibility that the repressing properties of LFB1/HNF1 might be attributed to the C-terminal portion of the protein, which contains the activation domains (15, 18) . To test this hypothesis, a hybrid protein was constructed in which the region of LFB1/HNF1 from aa 282 to the carboxyl end was fused downstream to the DNA-binding domain of the yeast transcription factor GAL4 (GAL4/LFB1). This chimaera is able to activate transcription from a GAL4 responsive promoter in cultured hepatoma cells (18) , but is unable to repress the LFBl/HNFl promoter activity in HepG2 cells (Fig. 4A) . It is worth noting that both the LFBl/HNFl DNA binding domain and GAL4/LFB1 proteins accumulate in the nuclei of transfected cells as previously reported (18) .
The results just described indicate that both the N-terminal DNA-binding domain and the C-terminal fragment of the molecule, although per se not sufficient, are required in order to observe the self-inhibiting activity of LFBl/HNFl.
A 60 amino add-long region in the C-terminus of LFBl/HNFl is required for full promoter-specific transcriptional inhibition
We next asked whether the integrity of the C-terminus portion of the protein is required for full inhibitory transcription properties. In particular, we wished to establish whether the domains required for the activation of liver-specific promoters in vivo, i.e. ADI (aa 546-628) and ADffl (aa 440-506) (17, 18) , are also involved in autorepression. For this purpose a set of Cterminal deletion mutants were tested in cotransfection experiments together with the pE8U-3.5CAT reporter plasmid. All these LFBl/HNFl derivatives were previously shown to accumulate in the nuclei of transfected cells at a level comparable to that of the wild type protein (18) . The results, shown in 
DISCUSSION
It has been recently suggested that LFBl/HNFl might play an important role in regulating the transcription driven by its own promoter. However, the results reported by different authors appear to be controversial as to whether LFBl/HNFl behaves as an activator or a repressor of the transcription of its own gene (24) (25) (26) In this paper, we present results indicating that the transcription of a reporter gene under the control of the LFBl/HNFl promoter is in fact subjected to negative regulation by the LFBl/HNFl protein, when transiently expressed in cultured hepatoma cells. This finding is in contradiction with the results reported by N. Miura and K.Tanaka (25) , who propose that LFBl/HNFl may bind to the proximal region of the promoter of its gene and transactivate its transcription in a synergistically fashion with HNF4. Zapp et al. (24) also observe a direct involvement of LFBl/HNFl in the activation of transcription from the Xenopus laevis LFBl/HNFl gene promoter. Our results are more consistent with the report of Kritis et al. (26) who observe an indirect negative autoregulatory loop responsible for the downregulation of LFBl/HNFl gene transcription. In line with the latter report, we could not identify any functional binding site for LFBl/HNFl on its 3.5 kb promoter region: we scanned the entire -3 . 5 kb promoter in search of protein/DNA interactions by DNasel footprinting and gel-shift experiments with a set of overlapping DNA fragments using purified LFBl/HNFl protein.
We could observe only a weak binding site centered at position -2677 from the transcriptional start site. However, this site has no involvement in the LFBl/HNFl self-inhibition, since its deletion in the pE8U-2.6CAT construct affects neither the efficiency of transcription nor the autorepression (data not shown). In addition computer assisted analysis of the -3.5kb LFBl/HNFl promoter sequence has not revealed the presence of canonical LFBl/HNFl DNA binding sites.
We have attempted to rule out relatively trivial explanations for this finding, such as competition for a limiting amount of a common target that is required for activation. Competition for a general transcription factor, a phenomenon known as 'squelching', seems unlikely on the basis of the following observations: in the same experimental system and at the same relative concentrations, LFBl/HNFl is a potent frans-activator of liver-specific promoters and does not inhibit promoters that do not contain LFBl/HNFl ds-acting elements (i.e. the RSV promoter). In addition, a construct carrying the activation domains of LFBl/HNFl fused to a heterologous DNA-binding domain would be sufficient to mediate squelching, whereas the GAL4/LFB1 fusion protein did not have any effect on the activity of the LFB1/HNF-1 promoter. We can also rule out the possibility that the over-expressed LFBl/HNFl is sequestering a related transcriptional activator or an essential cofactor, such as DCoH, via its dimerization domain, since a mutant protein in which this region has been substituted by the TAT dimerization domain is still capable of repression. Moreover, it is unlikely that LFBl/HNFl acts as a repressor of its own gene expression simply by displacing a more potent activator of transcription from its own promoter, because a truncated LFBl/HNFl molecule carrying only the DNA-binding domain, while able to repress the transcription from LFBl/HNFl-dependent promoters (31) , was inactive on the LFBl/HNFl promoter itself.
In addition to the DNA-binding domain we show that a sequence present in the carboxy-terminal region is also necessary for the autorepression effect. This region, tentatively located between aa 380 and 440, coincides with neither of the previously characterized liver-specific activation domains. One attractive possibility is that binding of LFBl/HNFl to its own promoter occurs only if stabilized by protein-protein interactions, mediated by this latter region, with a second, unknown transcription activator: this protein-protein interaction would ultimately result in 'quenching' (40) the transcriptional potential of the second activator.
Autoregulation appears to be a common feature of genes coding for eukaryotic transcription factors: both positive and negative autoregulatory loops have been found to play an important role in modulating transcription factor expression (reviewed in 41 and 42) . Many examples are known of positive and negative autoregulation of transcription factors: the muscle-specific factor MyoDl activates its own endogenous gene when transfected into fibroblast cells inducing their conversion to myoblasts (43) ; the erythroid-specific factor GAT A-1 (23) and the pituitary-specific POU-protein Pitl/GHFl (22, 44) have both been shown to positively regulate expression from their own promoter. Moreover, c-Fos generally represses its own transcription (21) .
Several reports have contributed to outline a network of regulatory interactions among liver-specific transcription factors (19, 20) . Transcription of the LFBl/HNFl gene depends on the presence of an active HNF4, thus indicating that, in the hierarchy of developmental regulation, HNF4 comes before the LFBl/HNFl factor. In this paper we present evidence suggesting that another level of possible regulation of the transcription of the LFBl/HNFl gene might be mediated by LFBl/HNFl itself. It is worth noting that also LFB3/vHNFl is capable of exerting a negative effect on LFBl/HNFl transcription in HepG2 cells (21 and G.P., unpublished observations). In previous work we have shown that LFB3/vHNFl mRNA, and the protein itself, is detected before LFBl/HNFl during the early stages of development and during organ-specific differentiation (5, 14) . It could be speculated that the autoregulation of LFBl/HNFl and the negative effect of LFB3/vHNFl on LFBl/HNFl transcription might play a role in guaranteeing the precise timing of the sequential activation of these two factors and their correct relative abundance, during critical stages of development and differentiation.
Further work will be required to elucidate the detailed mechanism by which this activity is brought about and to assess its biological relevance. At this stage, this phenomenon is just another tessera to be added to the complex mosaic of interdependent regulatory mechanisms potentially involved in liver-specific gene expression.
